Literature DB >> 14631225

Resection prior to liver transplantation for hepatocellular carcinoma.

Jacques Belghiti1, Alexandre Cortes, Eddie K Abdalla, Jean-Marc Régimbeau, Kurumboor Prakash, François Durand, Daniele Sommacale, Federica Dondero, Mickael Lesurtel, Alain Sauvanet, Olivier Farges, Reza Kianmanesh.   

Abstract

OBJECTIVE: To evaluate the feasibility and postoperative course of liver transplantation (LT) in cirrhotic patients who underwent liver resection prior to LT for HCC. SUMMARY BACKGROUND DATA: Although LT provides longer survival than liver resection for treatment of small HCCs, donor shortage and long LT wait time may argue against LT. The feasibility and survival following LT after hepatic resection have not been previously examined.
METHODS: Between 1991 and 2001, among 107 patients who underwent LT for HCC, 88 met Mazzafero's criteria upon pathologic analysis of the explant. Of these, 70 underwent primary liver transplantation (PLT) and 18 liver resection prior to secondary liver transplantation (SLT) for recurrence (n = 11), deterioration of liver function (n = 4), or high risk for recurrence (n = 3). Perioperative and postoperative factors and long-term survival were compared.
RESULTS: Comparison of PLT and SLT groups at the time of LT revealed similar median age (53 vs. 55 years), sex, and etiology of liver disease (alcohol/viral B/C/other). In the SLT group, the mean time between liver resection and listing for LT was 20 months (range 1-84 months). Overall time on LT waiting list of the two groups was similar (3 vs. 5 months). Pathologic analysis after LT revealed similar tumor size (2.2 vs. 2.3 cm) and number (1.6 vs. 1.7). Perioperative and postoperative courses were not different in terms of operative time (551 vs. 530 minutes), blood loss (1191 vs. 1282 mL), transfusion (3 vs. 2 units), ICU (9 vs. 10 days) or hospital stay (32 vs. 31 days), morbidity (51% vs. 56%) or 30-day mortality (5.7% vs. 5.6%). During a median follow-up of 32 months (3 to 158 months), 3 patients recurred after PLT and one after SLT. After transplantation, 3- and 5-year overall survivals were not different between groups (82 vs. 82% and 59 vs. 61%).
CONCLUSIONS: In selected patients, liver resection prior to transplantation does not increase the morbidity or impair long-term survival following LT. Therefore, liver resection prior to transplantation can be integrated in the treatment strategy for HCC.

Entities:  

Mesh:

Year:  2003        PMID: 14631225      PMCID: PMC1356170          DOI: 10.1097/01.sla.0000098621.74851.65

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  38 in total

1.  Survival after liver transplantation for hepatocellular carcinoma in cirrhosis according to the underlying liver disease.

Authors:  S Jonas; M Herrmann; N Rayes; T Berg; C Radke; S Tullius; U Settmacher; T Steinmüller; P Neuhaus
Journal:  Transplant Proc       Date:  2001 Nov-Dec       Impact factor: 1.066

2.  Feasibility and limits of caval-flow preservation during liver transplantation.

Authors:  J Belghiti; G M Ettorre; F Durand; D Sommacale; A Sauvanet; J T Jerius; O Farges
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

3.  Technical refinement in adult-to-adult living donor liver transplantation using right lobe graft.

Authors:  S T Fan; C M Lo; C L Liu
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

4.  Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

Authors:  M Minagawa; M Makuuchi; G Torzilli; T Takayama; S Kawasaki; T Kosuge; J Yamamoto; H Imamura
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

5.  Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

6.  Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy.

Authors:  J Figueras; E Jaurrieta; C Valls; E Ramos; T Serrano; A Rafecas; J Fabregat; J Torras
Journal:  J Am Coll Surg       Date:  2000-05       Impact factor: 6.113

7.  Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis.

Authors:  P E Majno; F P Sarasin; G Mentha; A Hadengue
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

Review 8.  Transplantation for liver and biliary cancer.

Authors:  R W Strong
Journal:  Semin Surg Oncol       Date:  2000 Sep-Oct

9.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

10.  Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors.

Authors:  R T Poon; S T Fan; C M Lo; C L Liu; J Wong
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

View more
  92 in total

1.  Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  Dig Dis Sci       Date:  2012-03-11       Impact factor: 3.199

2.  Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy?

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

3.  Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy?

Authors:  René Adam; Daniel Azoulay
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

Review 4.  Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Authors:  Maurizio Pompili; Giampiero Francica; Francesca Romana Ponziani; Roberto Iezzi; Alfonso Wolfango Avolio
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

5.  Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients.

Authors:  Robert J Wong; James Wantuck; Antonia Valenzuela; Aijaz Ahmed; Clark Bonham; Amy Gallo; Marc L Melcher; Glen Lutchman; Waldo Concepcion; Carlos Esquivel; Gabriel Garcia; Tami Daugherty; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

Review 6.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

7.  Resection and liver transplantation for HCC.

Authors:  Jacques Belghiti
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

8.  Impact of pathological features of primary hepatocellular carcinoma on the outcomes of intrahepatic recurrence management: single center experience from Southern Taiwan.

Authors:  Mahmoud Abdelwahab Ali; Wei-Feng Li; Jing-Houng Wang; Chih-Che Lin; Ying-Ju Chen; Ting-Lung Lin; Tsan-Shiun Lin; Sheng-Nan Lu; Chih-Chi Wang; Chao-Long Chen
Journal:  HPB (Oxford)       Date:  2016-08-25       Impact factor: 3.647

9.  Total laparoscopic liver resection in 78 patients.

Authors:  Lei Zhang; Ya-Jin Chen; Chang-Zhen Shang; Hong-Wei Zhang; Ze-Jian Huang
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

10.  Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.

Authors:  Wing Chiu Dai; See Ching Chan; Kenneth S H Chok; Tan To Cheung; William W Sharr; Albert C Y Chan; Simon H Y Tsang; James Y Y Fung; Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.